Incomplete response to therapy in intermediate- and high-risk thyroid cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://link.springer.com/content/pdf/10.1007/s12020-022-03187-5.pdf
Reference38 articles.
1. B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. Off. J. Am. Thyroid. Assoc. 26(1), 1–133 (2016). https://doi.org/10.1089/thy.2015.0020
2. R.M. Tuttle, A.S. Alzahrani. Risk stratification in differentiated thyroid cancer: from detection to final follow-up. J. Clin. Endocrinol. Metab. 2019. https://doi.org/10.1210/jc.2019-00177
3. F. Vaisman, R.M. Tuttle, Clinical assessment and risk stratification in differentiated thyroid cancer. Endocrinol. Metab. Clin. North Am. 48(1), 99–108 (2019). https://doi.org/10.1016/j.ecl.2018.11.002
4. A.S. Alzahrani, L. Albalawi, S. Mazi, N. Mukhtar, H. Aljamei, Y. Moria et al. How does the AJCC/TNM staging system eighth edition perform in thyroid cancer at a major middle eastern medical center. Endocr. Pr. 27(6), 607–613 (2021). https://doi.org/10.1016/j.eprac.2020.11.018
5. A. Campennì, D. Barbaro, M. Guzzo, F. Capoccetti, L. Giovanella, Personalized management of differentiated thyroid cancer in real life—practical guidance from a multidisciplinary panel of experts. Endocrine 70(2), 280–291 (2020). https://doi.org/10.1007/s12020-020-02418-x
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Predictors of response to Radioactive Iodine Therapy in Intermediate and high risk patients with papillary thyroid carcinoma;BMC Endocrine Disorders;2024-07-15
2. Course and predictors of excellent response to therapy in patients with differentiated thyroid cancer at long-term follow-up;Saudi Medical Journal;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3